Class III
Terminated
Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx Only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pha…
Why: Mislabeling
- Company
- Teva Pharmaceuticals USA
Parsippany, NJ, United States - Reported
- Feb 9, 2022
- Recall started
- Jan 7, 2022
- Ended
- Jun 1, 2023
- Where sold
- USA Nationwide
- Amount
- 6430 cartons
- Full product description
- Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx Only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0093-5455-42
- Lots / codes affected
- Lot#: 100018610, Exp 03/2022; 100021521, Exp 09/2022; 100024575, Exp 01/2023
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.